Related Experiment Video
Updated: Sep 28, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease
Kejal Kantarci1, YueCheng Xu, Maria M Shiung
1Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minn., USA.
Abstract:
This study compares the diagnostic accuracy of magnetic resonance (MR)-based hippocampal volumetry, single voxel (1)H MR spectroscopy ((1)H MRS) and MR diffusion-weighted imaging (DWI) measurements in discriminating patients with amnestic mild cognitive impairment (MCI), Alzheimer's disease (AD) and normally aging elderly. Sixty-one normally aging elderly, 24 MCI and 22 AD patients underwent MR-based hippocampal volumetry, (1)H MRS and DWI. (1)H MRS voxels were placed over both of the posterior cingulate gyri, and N-acetyl aspartate (NAA)/creatine (Cr), myoinositol (MI)/Cr and NAA/MI ratios were obtained. Apparent diffusion coefficient (ADC) maps were derived from DWI, and hippocampal borders were traced to measure hippocampal ADC. At 80% specificity, the most sensitive single measurement to discriminate MCI (79%) and AD (86%) from controls was hippocampal volumes. The most sensitive single measurement to discriminate AD from MCI was posterior cingulate gyrus NAA/Cr (67%). At high specificity (>85-90%), combinations of MR measures had superior diagnostic sensitivity compared with any single MR measurement for the AD vs. control and control vs. MCI comparisons. The MR measures that best discriminate more from less affected individuals along the cognitive continuum from normal to AD vary with disease severity. Selection of imaging measures used for clinical assessment or monitoring efficiency of therapeutic intervention should be tailored to the clinical stage of the disease.
Insights
Magnetic resonance imaging measures like hippocampal volume and spectroscopy can help distinguish between normal aging, mild cognitive impairment (MCI), and Alzheimer's disease (AD). Combining these MRI techniques improves diagnostic accuracy for early detection.
Area of Science:
- Neuroimaging
- Radiology
- Neurology
Background:
- Mild cognitive impairment (MCI) and Alzheimer's disease (AD) present diagnostic challenges.
- Accurate differentiation is crucial for timely intervention and treatment.
Purpose of the Study:
- To compare the diagnostic accuracy of three magnetic resonance (MR) techniques: hippocampal volumetry, MR spectroscopy ((1)H MRS), and diffusion-weighted imaging (DWI).
- To evaluate these techniques in discriminating between normally aging elderly, MCI patients, and AD patients.
Main Methods:
- Sixty-one healthy controls, 24 MCI patients, and 22 AD patients underwent MR imaging.
- Measurements included hippocampal volume, posterior cingulate gyrus (1)H MRS (NAA/Cr, MI/Cr, NAA/MI ratios), and hippocampal apparent diffusion coefficient (ADC) from DWI.
Main Results:
- Hippocampal volumes were the most sensitive single measure for discriminating MCI (79%) and AD (86%) from controls at 80% specificity.
- Posterior cingulate gyrus NAA/Cr ratio (67%) was the most sensitive single measure for discriminating AD from MCI.
- Combinations of MR measures showed superior diagnostic sensitivity compared to single measures for AD vs. control and control vs. MCI comparisons at high specificity (>85-90%).
Conclusions:
- The optimal MR measures for differentiating cognitive decline vary with disease severity.
- Tailoring MR imaging selection to the specific clinical stage is recommended for accurate assessment and monitoring therapeutic interventions.
